Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. FTC approves Cerner’s $1.3B Siemens health IT buy
Health information technology company Cerner announced this week that it won federal approval to move forward with its proposed $1.3 billion acquisition of Siemens Healthcare’s information technology business.
Cerner is throwing down straight cash for the deal, which was rumored in July and then confirmed in August. The companies still have other regulatory obstacles to pass before closing the deal. Read more
2. India considers price cap on medical devices
Indian regulators may impose price control measures on such medical devices as stents, catheters and implants in response to allegations of price gouging and bribery, according to a report in the Business Standard.
India’s health ministry and department of pharamaceuticals are considering a maximum retail price cap under the National Pharmaceutical Pricing Authority, which monitors the price of 348 medicines deemed essential, the Indian newspaper reported. Read more
1. Thoratec ousts Burbach, brings Grossman back
Thoratec said today that it’s replacing CEO Gary Burbach with his predecessor in the corner office, Keith Grossman, and issued preliminary 3rd-quarter guidance.
Grossman was Thoratec’s CEO from 1996-2006, when Burbach took over, and has had a seat on the board since then. He was president & CEO of Conceptus until it was acquired for $1.1 billion by Bayer in 2013. Read more